Trial of first lung cancer vaccine launched in seven countries
A 67-year-old man in the UK has become the first participant in a trial for a new lung cancer vaccine, BNT116, developed by BioNTech. The vaccine, which uses mRNA technology similar to COVID-19 vaccines, aims to instruct the immune system…